Northeast Health Services

Northeast Health Services in Attleboro, Massachusetts offers Spravato (esketamine), the first FDA-approved nasal spray for adults with treatment-resistant depression. Used alongside an oral antidepressant and administered in-office under close supervision, Spravato is fast-acting, with many clients feeling relief from depression symptoms within hours.

The Spravato program includes an initial evaluation and screening, an educational session, in-office administration by a qualified professional, regular monitoring, and ongoing therapeutic support. Spravato may be covered under either medical or pharmacy benefits depending on the plan.

Part of the Transformations Care Network, this clinic provides comprehensive outpatient mental health care, pairing Spravato with therapy, psychiatry, medication management, and TMS therapy. In-person and telehealth options are available, and the practice is in-network with most major insurers, including Medicare and Medicaid.